Similar articles

• Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

  Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Aaron SD, et al. Ann Intern Med. 2007 Apr 17;146(8):545-55. doi: 10.7326/0003-4819-146-8-200704170-00152. Epub 2007 Feb 19. Ann Intern Med. 2007. PMID: 17310045 Clinical Trial.
• Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?

  Gillissen A. Gillissen A. Am J Respir Crit Care Med. 2008 Jul 1;178(1):105; author reply 106-7. doi: 10.1164/ajrccm.178.1.105. Am J Respir Crit Care Med. 2008. PMID: 18565963 No abstract available.
• A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

  Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K. Donohue JF, et al. Treat Respir Med. 2004;3(3):173-81. doi: 10.2165/00151829-200403030-00005. Treat Respir Med. 2004. PMID: 15219176 Clinical Trial.
• Tiotropium for chronic obstructive pulmonary disease.

  [No authors listed] [No authors listed] Drug Ther Bull. 2003 Feb;41(2):15-6. doi: 10.1136/dtb.2003.41215. Drug Ther Bull. 2003. PMID: 12630336 Review.
• Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?

  Tennant RC, Erin EM, Barnes PJ, Hansel TT. Tennant RC, et al. Curr Opin Pharmacol. 2003 Jun;3(3):270-6. doi: 10.1016/s1471-4892(03)00047-x. Curr Opin Pharmacol. 2003. PMID: 12810191 Review.